EGFR and glioblastoma: Evidence suggests the simultaneous gain of chromosome 7 and loss of chromosome 10 is associated with EGFR amplification and the PTEN deletion mutation, emphasising the relationship between chromosomal alterations and oncogenic drivers in GBM progression [14].